anmelden
OMX Nordic 40
2.612,41
PKT
-23,79
PKT
-0,90
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu OMX Nordic 40-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 17.11.21 | AstraZeneca Buy | UBS AG | |
| 15.11.21 | AstraZeneca Buy | Deutsche Bank AG | |
| 15.11.21 | AstraZeneca Outperform | Credit Suisse Group | |
| 15.11.21 | A.P. Moeller - Maersk A-S (B) Neutral | JP Morgan Chase & Co. | |
| 12.11.21 | AstraZeneca Buy | UBS AG | |
| 12.11.21 | AstraZeneca Buy | Jefferies & Company Inc. | |
| 12.11.21 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 12.11.21 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 11.11.21 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 10.11.21 | Nokia Buy | UBS AG | |
| 10.11.21 | ABB (Asea Brown Boveri) Buy | UBS AG | |
| 10.11.21 | AstraZeneca Overweight | Barclays Capital | |
| 05.11.21 | ABB (Asea Brown Boveri) Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 05.11.21 | Kone Neutral | UBS AG | |
| 04.11.21 | Novo Nordisk Neutral | Credit Suisse Group | |
| 04.11.21 | Novo Nordisk Overweight | Barclays Capital | |
| 04.11.21 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 03.11.21 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 03.11.21 | Volvo (B) Conviction Buy List | Goldman Sachs Group Inc. | |
| 03.11.21 | Novo Nordisk Outperform | Bernstein Research | |
| 03.11.21 | Novo Nordisk Neutral | UBS AG | |
| 03.11.21 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 03.11.21 | ABB (Asea Brown Boveri) Hold | Jefferies & Company Inc. | |
| 02.11.21 | AstraZeneca Buy | UBS AG | |
| 02.11.21 | Kone Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 01.11.21 | ABB (Asea Brown Boveri) Conviction Buy List | Goldman Sachs Group Inc. | |
| 01.11.21 | Nokia Equal Weight | Barclays Capital | |
| 01.11.21 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 29.10.21 | Nokia Overweight | JP Morgan Chase & Co. | |
| 29.10.21 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 29.10.21 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 29.10.21 | Nokia Buy | Goldman Sachs Group Inc. | |
| 29.10.21 | Kone Buy | Kepler Cheuvreux | |
| 29.10.21 | Nokia Buy | UBS AG | |
| 29.10.21 | Nokia Buy | Kepler Cheuvreux | |
| 29.10.21 | Nokia Buy | Deutsche Bank AG | |
| 29.10.21 | Nokia Neutral | Credit Suisse Group | |
| 29.10.21 | Nokia Overweight | JP Morgan Chase & Co. | |
| 29.10.21 | Kone Outperform | Credit Suisse Group | |
| 28.10.21 | Kone Neutral | Goldman Sachs Group Inc. |